← Back to headlines
Barclays Initiates AbbVie with Overweight Rating on Growth Potential
Barclays has assigned an 'Overweight' rating to AbbVie (ABBV), citing the pharmaceutical company's significant growth potential.
23 Feb, 18:13 — 23 Feb, 18:13
ℹOnly 1 source covers this story
